Biospecimen Holdings

Prairie Capital Fund VII

Provider of biospecimens and CRO services to global biopharma and diagnostic customers through a consortium of companies

Investment Team

Location: San Diego, CA and Pasadena, CA

Investment Date: April 2026

Industry: Healthcare

“After more than a year of carefully considering potential buyers for my company, I ultimately chose Prairie over several competing investment firms to acquire Cantor BioConnect. Throughout the process, Prairie demonstrated exceptional professionalism and established itself as a trusted leader and partner in the industry. I am extremely pleased with my decision to partner with Prairie and confident they will take Cantor BioConnect to the next level.”

David Cantor

Founder, Cantor BioConnect

Investment Team

Michael Praljak
Michael Praljak
Vice President
Sean McNally
Sean McNally
Partner